M. E. Kasap Et Al. , "Distrupting Hypoxia-Induced Metabolic Adaptation in Oral Cavity Carcinoma Cells: Identifying the Potential of Rivaroxaban as an Anti-Coagulant Agent," MOLECULAR ONCOLOGY , vol.18, no.S1, pp.146, 2024
Kasap, M. E. Et Al. 2024. Distrupting Hypoxia-Induced Metabolic Adaptation in Oral Cavity Carcinoma Cells: Identifying the Potential of Rivaroxaban as an Anti-Coagulant Agent. MOLECULAR ONCOLOGY , vol.18, no.S1 , 146.
Kasap, M. E., Bayrak, Ö., Bayrak, A. F., Başbınar, Y., & Bayrak, S., (2024). Distrupting Hypoxia-Induced Metabolic Adaptation in Oral Cavity Carcinoma Cells: Identifying the Potential of Rivaroxaban as an Anti-Coagulant Agent. MOLECULAR ONCOLOGY , vol.18, no.S1, 146.
Kasap, Mustafa Et Al. "Distrupting Hypoxia-Induced Metabolic Adaptation in Oral Cavity Carcinoma Cells: Identifying the Potential of Rivaroxaban as an Anti-Coagulant Agent," MOLECULAR ONCOLOGY , vol.18, no.S1, 146, 2024
Kasap, Mustafa E. Et Al. "Distrupting Hypoxia-Induced Metabolic Adaptation in Oral Cavity Carcinoma Cells: Identifying the Potential of Rivaroxaban as an Anti-Coagulant Agent." MOLECULAR ONCOLOGY , vol.18, no.S1, pp.146, 2024
Kasap, M. E. Et Al. (2024) . "Distrupting Hypoxia-Induced Metabolic Adaptation in Oral Cavity Carcinoma Cells: Identifying the Potential of Rivaroxaban as an Anti-Coagulant Agent." MOLECULAR ONCOLOGY , vol.18, no.S1, p.146.
@article{article, author={Mustafa Ertunga Kasap Et Al. }, title={Distrupting Hypoxia-Induced Metabolic Adaptation in Oral Cavity Carcinoma Cells: Identifying the Potential of Rivaroxaban as an Anti-Coagulant Agent}, journal={MOLECULAR ONCOLOGY}, year=2024, pages={146} }